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NOTE
THE SCAMMER AND THE CHARLATAN:
REGULATING HEALTH FRAUDSTERS IN
THE TIME OF COVID-19
BRITTANY M. RIEHM*
I. INTRODUCTION
Arthritis got you down? Or maybe you want an oil that cures cancer?
How about a mineral that prevents aging? Oh, you say a novel virus is what
troubles you? Well, they have a cure for that. Wherever there is fear,
desperation, or uncertainty, bad actors will creep out of the shadows to
profit through scam cure-alls that just happen to fix the ailment of the
moment.
In this paper, I will discuss the individual and intersecting roles of the
Federal Trade Commission (FTC) and the US Food and Drug Administra-
tion (FDA) in combatting health fraud. I will begin with an overview of two
broad categories of health fraudsters that I have named “the simple scam-
mer” and “the creative charlatan.” I will start with the simple scammer, who
operates a low-level scam in which he claims his very basic product is a
cure for essentially everything. Next, I will describe the creative charlatan,
who runs a more complex scheme in which he appropriates and misapplies
scientific research to confuse consumers into believing his treatment is
legitimate.
Following that, I will explain how the FDA and FTC work together to
regulate healthcare products for safety, effectiveness, and advertising accu-
racy. I will also discuss the independent and intersecting roles of the agen-
cies in bringing down health fraudsters. From there, I will provide an
overview of the recent coronavirus outbreak and discuss where health
* Brittany Riehm is a third-year law student at the University of St. Thomas School of
Law. She expresses sincere gratitude to University of St. Thomas School of Law Professor Eliza-
beth Schiltz for the constant encouragement, guidance, and insightful commentary from the out-
line stage to the final draft. She also thanks Jonathan Wolf for his thoughtful review and
constructive feedback. Further, she is grateful to Kathleen Riehm for her patience and support
throughout the process.
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fraudsters are currently operating (in the simple scam arena) and where I
predict they will go (to the more complex scheme of the creative charlatan).
I will then walk through some different methods of the simple scam-
mer by introducing individual actors fraudulently selling colloidal silver
and essential oils as coronavirus cures. Additionally, I will provide exam-
ples of creative charlatans marketing unproven stem cell therapies and dis-
cuss how the FDA and FTC are countering these illegal activities. Next, I
will explain why I think a creative charlatan coronavirus scheme is on the
horizon and what that may mean for consumers. I will finish by arguing that
the only true way to protect consumers is proactive and aggressive action
by a joint task force of the FDA and FTC designed strictly to combat medi-
cal scammers during times of crisis.
II. OVERVIEW OF SCAMMERS
There are two types of scammers that I will discuss in this paper. My
term for the first category of scammers is “the simple scammer.” The sim-
ple scammer hawks snake oil. His products have very little or no medicinal
value, yet the simple scammer advertises them as some ancient cure-all be-
ing kept secret from mainstream society. There is a reason this category of
scammers markets the ancientness of its products: the simple scammer is
unoriginal. The products do not really change—the peddlers merely add the
ailment of the moment to the endless list of what their product allegedly
“cures.” The simple scammer takes advantage of consumers’ fears and
weaknesses in order to profit. The simple scammer does not get rich off of
one individual, so he needs to recruit a loyal base in order to build his
empire. Generally, his products defraud individual consumers of hundreds,
rather than thousands, of dollars. One of the greatest risks to consumers
caught in one of these scams is that they will put off seeking effective medi-
cal treatment for an illness because they are sold on the lies of the simple
scammer. During a global pandemic, these consumers might also pose a
risk to others if they believe they have achieved immunity from the
coronavirus and thus refuse to follow the safety guidelines established by
the Centers for Disease Control and Prevention.
Simple scams, however, are fairly easy to detect. Because these scam-
mers are just recycling old fraudulent products, there are generally plenty of
warnings and discrediting information available to anyone who runs a basic
Google search. Additionally, these scammers cast such a wide net when
listing ailments that will be “cured” by their product that the breadth of the
claims alone will raise a red flag for most moderately savvy consumers.
The simple scam is the category in which many medical scams origi-
nate and where low-level scammers remain. The public is currently plagued
with a multitude of unscrupulous actors hawking archaic products
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(predominantly colloidal silver and essential oils) as faux cures for COVID-
19.
The second category of scammer I am going to discuss, I have termed
“the creative charlatan.” The creative charlatan is a much more complex
evolution of the simple scammer. Creative charlatans appropriate legitimate
science and misapply it in order to market unproven treatments to the public
with an air of authority. These scams are much harder for consumers to spot
because creative charlatans weave valid medical and scientific terms into
their scams. The creative charlatan throws budding science into its market-
ing materials to give consumers false confidence and sprinkles in pseudo-
science to confuse consumers. The creative charlatan may also ride on the
coattails of legitimate (and respected) medical research institutions in the
research trial stage by pointing to them as proof that its similar-sounding
treatment is effective.
The creative charlatan can get rich off of far fewer consumers than the
simple scammer because the creative charlatan’s products cost individual
consumers thousands of dollars. Additionally, the creative charlatan builds
his own repeat business model by targeting consumers with illnesses that
naturally ebb and flow over time. The charlatan takes credit for the good
days and blames the bad on needing another “treatment.” Further, the risks
to consumers in this more complex scam are much greater because of the
invasive nature of these sketchy “treatments.” Simple scammers generally
peddle useless, but fairly benign products; whereas creative charlatans often
perform very risky procedures that can themselves have irreversible adverse
health effects.
While we have not yet reached the late stages of creative charlatanism
with coronavirus scams, I predict that is where we are heading. As legiti-
mate vaccines are being developed, more advanced scams will be rolled
out.
III. ROLES OF THE FDA AND THE FTC IN REGULATING HEALTHCARE
CLAIMS
In the United States, the federal government empowers administrative
agencies, such as the FDA and the FTC, to combat fraud and protect con-
sumers. The FDA was formed in 19061 to, among other things, ensure the
safety of drugs intended for human use.2 Since its humble origins, the
FDA’s jurisdiction has expanded to the regulation of vaccines and other
biological products,3 medical devices,4 and many other products intended
1. Federal Food and Drug Act of 1906, Pub. L. No. 59-384, 34 Stat. 768, repealed by
Federal Food, Drug, and Cosmetic Act of 1938, 21 U.S.C. § 301.
2. What Does FDA Do?, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/about-fda/fda-
basics/what-does-fda-do (Mar. 28, 2018).
3. FDA General Enforcement Regulations, 21 C.F.R. § 1.78 (2020).
4. 21 C.F.R. § 1.76.
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for human or animal use. The FTC was created in 1914,5 in part, to prevent
the use of “unfair or deceptive acts or practices” in commercial advertis-
ing.6 Despite these agencies being put in place for the purpose of protecting
consumers, the public continues to “spend billions of dollars a year on
fraudulently marketed health-related products and treatments that not only
are unproven and often useless, but sometimes also are dangerous.”7
A. The Food and Drug Administration’s Role in Combatting Medical
Fraud
There are two relevant FDA regulations at play in the medical scams
discussed in this paper: approval for drugs or biologics8 to enter the market
and approval for human studies. Before a new drug or biologic can legally
be put on the market, it must be proven safe and effective by the FDA.9 The
FDA determines safety and effectiveness through a pre-market review,
wherein it reviews the results of controlled clinical trials completed by a
private company that wants to put the new drug or biologic on the market.10
Most companies seeking FDA market approval for an innovative new drug
will have the results of that pre-market review in six months or less.11 The
first category of scams (simple scams) tend to fall under the pre-market
approval regulatory umbrella of the FDA.
The FDA review process for experimental medical therapies is aimed
at ensuring the safety of participants and upholding scientific rigor of the
study to allow the results to be analyzed for safety and effectiveness.12
Thus, the FDA requires any approved experiments to occur in the form of
controlled human studies.13 In order to gain FDA approval for a human
study, the experimenter must first produce sufficient data from animal stud-
ies to ensure his product is reasonably safe for use on human participants.14
The second category of scams (schemes of the creative charlatan) tend to
fall under the clinical studies regulation of the FDA because of the invasive
nature and complexities involved in the marketed treatment. The creative
5. 15 U.S.C. § 41.
6. 15 U.S.C. § 45(a)(2).
7. Miracle Health Claims, FED. TRADE COMM’N (Nov. 2011), https://
www.consumer.ftc.gov/articles/0167-miracle-health-claims.
8. FDA Biological Products: General, 21 C.F.R. § 600.3(h) (2020) (A biologic is “a virus,
therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic
product, protein, or analogous product, or arsphenamine or derivative of arsphenamine (or any
other trivalent organic arsenic compound), applicable to the prevention, treatment, or cure of a
disease or condition of human beings.”).
9. 21 U.S.C. § 355(a).
10. Id.
11. About FDA Product Approval, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/news-
events/approvals-fda-regulated-products/about-fda-product-approval (Dec. 29, 2017).
12. FDA Investigational New Drug Application, 21 C.F.R. § 312.22(a) (2020).
13. Id.
14. 21 C.F.R. § 312.22(c).
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charlatan often mimics legitimate FDA-approved clinical studies but poses
a much greater risk to consumers because he lacks the oversight to ensure
safety and scientific rigor.
The FDA has various tools it can use to enforce its regulations. It may
issue a warning letter to the violator, informing him of specific violations
and requesting the violator respond within a specified period of time with a
detailed plan of how he intends to promptly correct any violation.15 The
FDA may also request another government agency take action against a
perpetrator. For example, the FDA may recommend the United States bring
one or more of the following actions against the perpetrator: injunctive re-
lief,16 seizure to remove the violative goods from the market,17 civil penal-
ties,18 and/or criminal penalties19 for particularly egregious cases.
B. The Federal Trade Commission’s Role in Combatting Medical Fraud
Health fraudsters running a simple scam or creative charlatan scheme
both fall under the jurisdiction of the FTC’s deceptive advertisement pro-
tections. The FTC requires a company to have reliable scientific evidence to
support any claims it makes that its product can treat or prevent a disease.20
Therefore, if someone puts their drug on the market without first obtaining
FDA approval, they are also running afoul of the FTC.
The FTC regulates advertisements by stopping companies who make
deceptive or fraudulent claims about their products.21 However, unlike the
FDA, the FTC has more enforcement power within its own agency. For
example, the Commission can conduct its own hearing and issue a cease
and desist order to the business or individual.22 Further violations after such
an order has been entered by the Commission may result in the Attorney
General pursuing immediate and permanent injunctive relief and civil pen-
alties of up to $10,000 for each violation in federal court.23 Additionally,
the FTC may bring its own action in federal court to enjoin the dissemina-
tion of an advertisement24 prior to or during a Commission proceeding in-
tended to address the violative behavior in order to protect consumers in the
interim.25 The FTC may also seek to freeze a violator’s assets and get com-
pensation for victims.26
15. 21 U.S.C. § 336.
16. 21 U.S.C. § 332(a).
17. 21 U.S.C. § 334(d)(1).
18. 21 U.S.C. § 333.
19. Id.
20. 15 U.S.C. § 52.
21. 15 U.S.C. § 45(a).
22. 15 U.S.C. § 45(b).
23. 15 U.S.C. § 45(l).
24. 15 U.S.C. § 53(b).
25. Fed. Trade Comm’n v. Thomsen-King & Co., 109 F.2d 516, 519 (7th Cir. 1940).
26. 15 U.S.C. § 53(b).
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C. The Intersection of the FDA and FTC
Although the FDA and FTC are each a distinct government entity,
their regulatory authority often intersects with respect to fraudulent health-
care claims. The FDA is charged with regulating the actual products for
safety, effectiveness, and accurate labeling, and the FTC regulates adver-
tisement claims for accuracy.
Recognizing the common intersection between the objectives of the
FDA and FTC, in 1971 the two agencies entered into a Memorandum of
Understanding wherein they agreed to exchange “complete information so
that both agencies will be utilized to the maximum effectiveness in the pub-
lic interest.”27 Each agency designated a liaison officer to communicate to
the other agency about developments in areas of mutual concern.28 At the
end of this article, I will discuss the potential advantages of these agencies
taking it a step further and creating a combined task force to combat
coronavirus scams.
Next, I will provide an overview of the current coronavirus pandemic
and the FDA and FTC’s current role in combatting scam medical treatments
being marketed to the public.
IV. CORONAVIRUS
A novel coronavirus was discovered in early January 2020, following a
pneumonia-like illness that had infected over forty citizens of Wuhan,
China in late 2019.29 Within weeks of that discovery, the coronavirus
spread to Thailand, Japan, and Korea.30 The first confirmed case in the
United States was reported on January 21, 2020.31 As of the date of this
writing, nearly every country in the world has had confirmed cases of the
virus.32 The World Health Organization declared the coronavirus a global
health emergency at the end of January 2020.33 There are currently many
27. Memorandum of Understanding Between the Federal Trade Commission and the Food
and Drug Administration, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/about-fda/domestic-
mous/mou-225-71-8003 (Dec. 15, 2017).
28. Id.
29. Novel Coronavirus (2019-nCoV) Situation Report - 1, WORLD HEALTH ORG. 1 (Jan. 21,
2020).
30. Id.
31. Roni Rabin, First Patient with Wuhan Coronavirus Is Identified in the U.S., N.Y. TIMES,
Jan. 21, 2020; updated May 7, 2020, https://www.nytimes.com/2020/01/21/health/cdc-
coronavirus.html.
32. Coronavirus Disease 2019: World Map, CENTERS FOR DISEASE CONTROL AND PREVEN-
TION, https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/world-map.html (June 6, 2020).
33. Sui-Lee Wee et al., W.H.O. Declares Global Emergency as Wuhan Coronavirus Spreads,
N.Y. TIMES, https://www.nytimes.com/2020/01/30/health/coronavirus-world-health-organiza
tion.html (Apr. 16, 2020).
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potential COVID-19 vaccines in development, but only three which have
been authorized for use (and only in certain countries).34
While heroes around the globe work tirelessly to implement life-saving
measures and to discover medical treatments for this novel virus, a seem-
ingly endless number of unscrupulous actors have crept out of the wood-
work proclaiming to hold the cure. Unfortunately, while the coronavirus is
new, marketing fraudulent cures and preventative measures to a population
of terrified and desperate consumers is a tale as old as time. In fact, many of
the fraudulent claims are simply echoes of what have been falsely marketed
in the past. Products such as colloidal silver and essential oils have been
marketed as cure-alls for decades and are now fraudulently being sold as
COVID-19 cures.
The FTC and FDA have joined forces in an attempt to promptly stop
fraudsters from making scientifically unsupported claims about their prod-
ucts’ ability to prevent and/or treat COVID-19.35 The agencies are sending
joint warning letters to businesses found to be selling fake coronavirus
treatments, and are giving violators forty-eight hours to inform the agencies
of their plan to promptly correct the violations.36 If a business fails to take
immediate corrective measures, the FDA may recommend criminal prose-
cution and/or a federal injunction, and the FTC may pursue financial reme-
dies on behalf of consumers.37
Both agencies are taking the scams seriously. The FTC Chairman Joe
Simons pointed out that the public is already anxious over the COVID-19
pandemic, and said, “What we don’t need in this situation are companies
preying on consumers by promoting products with fraudulent prevention
and treatment claims.”38 According to a March 9, 2020, FDA news release,
“The FDA is particularly concerned that products that claim to cure, treat or
prevent serious diseases like COVID-19 may cause consumers to delay or
stop appropriate medical treatment, leading to serious and life-threatening
harm.”39 The FDA has created a task force dedicated solely to the purpose
34. Coronavirus Disease (COVID-19): Vaccines, WORLD HEALTH ORG., https://
www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines (Oct. 28, 2020).
35. FTC, FDA Send Warning Letters to Seven Companies About Unsupported Claims That
Products Can Treat or Prevent Coronavirus, FED. TRADE COMM’N (Mar. 9, 2020), https://
www.ftc.gov/news-events/press-releases/2020/03/ftc-fda-send-warning-letters-seven-companies-
about-unsupported.
36. Lesley Fair, FTC, FDA Warn Companies Making Coronavirus Claims, FED. TRADE
COMM’N (Mar. 9, 2020, 9:56 AM), https://www.ftc.gov/news-events/blogs/business-blog/2020/03/
ftc-fda-warn-companies-making-coronavirus-claims.
37. Id.
38. Coronavirus Update: FDA and FTC Warn Seven Companies Selling Fraudulent Prod-
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of detecting and stopping “fraudulent products related to COVID-19,”40
which has successfully removed over one hundred fraudulent listings from
the market as of the date of this writing.41
V. THE SIMPLE SCAMMER—WHERE WE ARE NOW
The current COVID-19 scams flooding the market are the low-level
simple scams described earlier. As of the date of this writing, the FDA has
sent out 145 warning letters,42 and the FTC has sent out 390 warning let-
ters43 to individuals or companies marketing fraudulent COVID-19 treat-
ments.44 The alleged treatments primarily take the form of colloidal silver
or essential oils, neither of which have any proven effect in preventing,
mitigating, or curing COVID-19, or any other ailment for that matter. In
this section, I will offer a brief overview of colloidal silver and essential
oils as historic scams. I will then provide details about a small selection of
the simple scammers marketing those products who are under scrutiny for
alleging to hold the cure for COVID-19.
A. Colloidal Silver
Unsubstantiated claims that colloidal silver can cure a variety of ail-
ments not only lack originality but have in fact been specifically prohibited
by the FDA for over two decades.45 In order to gain FDA approval, manu-
facturers of colloidal silver must participate in clinical investigations de-
signed to obtain evidence that the product is “safe and effective for the
purpose intended.”46 This seems like a pretty low bar considering propo-
nents’ claims that it has been a known success for over one hundred years.
Colloidal silver manufacturers were even put on notice no later than 199947
that the FDA intended to declare colloidal silver as not recognized as safe
or effective to treat anything unless scientific evidence was produced to
show otherwise. Yet, to date, no studies have been done that prove colloidal
silver’s safety and effectiveness. Thus, it remains banned from being adver-
tised as a cure for anything. In fact, animal studies that have been conducted
revealed that use of colloidal silver may actually cause seizures and other
40. Id.
41. Fraudulent Coronavirus Disease 2019 (COVID-19) Products, U.S. FOOD & DRUG AD-
MIN., https://www.fda.gov/consumers/health-fraud-scams/fraudulent-coronavirus-disease-2019-
covid-19-products (last visited Jan. 30, 2021).
42. Warning Letters, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/inspections-compli
ance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
(last visited Jan. 30, 2021).
43. FTC Coronavirus Warning Letters to Companies, FED. TRADE COMM’N, https://
www.ftc.gov/coronavirus/enforcement/warning-letters (last visited Jan. 31, 2021).
44. Some of these letters are overlapping.
45. FDA Requirements for Specific New Drugs or Devices, 21 C.F.R. § 310.548 (2020).
46. Id.
47. Over-the-Counter Drug Products Containing Colloidal Silver Ingredients or Silver Salts,
64 Fed. Reg. 44653 (Aug. 17, 1999) (codified as 21 C.F.R. § 310.548).
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neurological problems, kidney damage, stomach issues, headaches, fatigue,
skin irritation, and argyria (a permanent, irreversible condition that turns the
skin, organs, deep tissues, nails, and gums a bluish-gray).48
The number of companies fraudulently selling colloidal silver as an
effective means to prevent, mitigate, and treat COVID-19 is growing rap-
idly and includes, but is definitely not limited to, Xephyr LLC d/b/a N-
Ergetics; The Jim Bakker Show; Gaia’s Whole Healing Essentials; JRB En-
terprise Group d/b/a Anti Aging Bed; and Colloidal Vitality LLC.49 The
outlandish claims made by these companies go far beyond colloidal silver
being sold as a cure-all, although that is the current focus of the FDA and
FTC, and each bad actor presents his own unique brand of fraud.
Claims made about the miraculous effects of colloidal silver are not
supported by science and run afoul of the FDA’s prohibition on the sale of
unapproved and misbranded drugs.50 These claims also violate the FTC’s
prohibition on advertising that a product can treat a disease without reliable
scientific support.51
1. Xephyr LLC d/b/a N-Ergetics
One of the first culprits to receive an FDA-FTC joint warning letter
(dated March 6, 2020) for fraudulently selling colloidal silver products as
safe and effective at-home treatments for the coronavirus was Xephyr LLC
d/b/a N-Ergetics (“N-Ergetics”).52 The unsupported claims made by N-
Ergetics include, but are not limited to, the following:
Colloidal Silver is still the only known anti-viral supplement
to kill all seven of these Human Coronaviruses.
Preventing The Contraction Of The Novel Coronavirus is El-
ementary. . . . Even though there are no vaccines available to
combat these coronaviruses, there is a home remedy of Colloidal
Silver 100 ppm that has worked effectively on coronaviruses suc-
cessfully for the last 123 years.
Colloidal Silver kills all viruses.53
Following the March 6 letter, N-Ergetics scaled back on its unfounded
claims and added a disclaimer informing consumers that its products are not
scientifically proven to have any medical benefit with respect to the
coronavirus. However, these changes have been described by the Depart-
48. BACKGROUNDER, NAT’L CENTER FOR COMPLEMENTARY AND ALTERNATIVE MEDICINE,
FACT SHEET D209, at 2 (Dec. 2006).
49. Warning Letters, FED. TRADE COMM’N, https://www.ftc.gov/enforcement/warning-let
ters?field_tags_tid%5B0%5D=361 (last visited Dec. 23, 2020).
50. 21 U.S.C. § 355(a); 21 U.S.C. § 352.
51. 15 U.S.C. § 52.
52. Warning Letter from U.S. Food & Drug Admin. and Fed. Trade Comm’n to Xephyr,
LLC dba N-Ergetics (Mar. 6, 2020), https://www.fda.gov/inspections-compliance-enforcement-
and-criminal-investigations/warning-letters/xephyr-llc-dba-n-ergetics-604588-03062020.
53. Id.
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ment of Justice in a complaint filed in United States District Court as a
mere attempt by N-Ergetics and its facilitators “to cloak their claims to
prevent liability, while continuing to make the same substantive claims.”54
On May 14, 2020, the United States District Court for the Eastern Dis-
trict of Oklahoma issued a Temporary Restraining Order requiring N-Erget-
ics to, among other things, immediately stop selling any drug, including
colloidal silver, and “submit to FDA for its review and approval a recall
strategy for [N-Ergetics’] colloidal silver products.”55 N-Ergetics was fur-
ther ordered to post a copy of the Temporary Restraining Order on any and
all of its websites and in a common area at each of its facilities.56
According to the Department of Justice, the operators of N-Ergetics
took down their sales site and “posted a message offering refunds to their
customers” in response to the lawsuit.57
2. Colloidal Vitality LLC
Colloidal Vitality LLC has been making claims that one or two tea-
spoons of its Structured Silver Advanced Formula will “[attach] to bacteria,
yeast, and viruses rendering them ineffective and boosting your immune
system” and that “it’s actually widely acknowledged in both science and the
medical industry that ionic silver kills coronaviruses.”58 The FDA and FTC
sent Colloidal Vitality a warning letter on March 6, 2020, to remove the
fraudulent statements from its advertising platforms.59
As of the date of this writing, while Colloidal Vitality continues to sell
colloidal silver, it appears to have removed its unsubstantiated claims with
respect to its products’ ability to cure the coronavirus from its website and
added FDA-required disclaimers to both its website and Facebook page.
54. Court Orders Oklahoma Company to Stop Selling Colloidal Silver as Treatment for
COVID-19, U.S. DEP’T OF JUST. (May 14, 2020), https://www.justice.gov/opa/pr/court-orders-
oklahoma-company-stop-selling-colloidal-silver-treatment-covid-19.
55. Temporary Restraining Order at 3–4, United States v. Xephyr, No. 06:20-CV-00140
(E.D. Okla. May 14, 2020), https://www.justice.gov/opa/press-release/file/1276661/download.
The court issued a preliminary injunction against N-Ergetics on May 27, 2020, which essentially
extended the terms of the temporary order until superseded by a final judgment or dismissal of the
court action. Order of Preliminary Injunction, United States v. Xephyr, No. 06:20-CV-00140





57. Court Orders Oklahoma Company to Stop Selling Colloidal Silver as Treatment for
COVID-19, U.S. DEP’T OF JUST. (May 14, 2020), https://www.justice.gov/opa/pr/court-orders-
oklahoma-company-stop-selling-colloidal-silver-treatment-covid-19.
58. Warning Letter from U.S. Food & Drug Admin. and Fed. Trade Comm’n to Colloidal
Vitality LLC (Mar. 6, 2020), https://www.fda.gov/inspections-compliance-enforcement-and-crim
inal-investigations/warning-letters/colloidal-vitality-llcvital-silver-604885-03062020.
59. Id.
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3. The Jim Bakker Show
Another recipient of a joint warning letter from the FDA and FTC on
March 6, 2020, was the ever-persistent fraudster, Jim Bakker. His current
company, The Jim Bakker Show, was determined to be fraudulently selling
colloidal silver products as a means of preventing and treating COVID-19
from home.60 Jim Bakker’s twist is that he peddles his fraudulent products
under the guise of a religious leader. Jim Bakker is a televangelist who
currently specializes in selling “end of the world” products to viewers.61
The fear and uncertainty surrounding the novel coronavirus outbreak pro-
vided Bakker the perfect fuel for his fire of deception.
The FDA and FTC determined that The Jim Bakker Show erroneously
claimed that its colloidal silver products have been proven to effectively kill
all known viruses and “every pathogen it has ever been tested on,” and that
its products therefore would be able to kill COVID-19 as well.62 The “Sil-
ver Solution” The Jim Bakker Show advertised was intended to be put in a
nebulizer and the steam breathed in, allegedly to kill the virus and “any
other infection” in the lungs.63 Like those from Colloidal Vitality, the fan-
tastic claims made by The Jim Bakker Show were unfounded, violating
regulations of both the FDA and FTC.64
However, it is worth noting that, unlike Colloidal Vitality’s seemingly
prompt response to a slap on the wrist for its violations, Jim Bakker is less
likely to roll over quietly. While The Jim Bakker Show has, at least tempo-
rarily, ceased its colloidal silver sales, this is not the first time Bakker has
dabbled in consumer fraud, and seems unlikely to be the last.
Jim Bakker and his previous wife, Tammy Bakker, were among the
first televangelists.65 Together they used telethons to build a multimillion-
dollar empire, and in addition to purchasing multiple houses, fancy cars,
and other fine things for themselves, the Bakkers used that money to build a
religious theme park and resort complex.66 In 1989, Jim Bakker was con-
victed of fraud and conspiracy67 for a scheme in which he bilked his relig-
ious followers out of over $1.5 million by overselling shares for timeshare-
60. Warning Letter from U.S. Food & Drug Admin. and Fed. Trade Comm’n to The Jim
Bakker Show (Mar. 6, 2020), https://www.fda.gov/inspections-compliance-enforcement-and-
criminal-investigations/warning-letters/jim-bakker-show-604820-03062020.
61. Lauren Effron, Andrew Paparella & Jeca Taudte, The Scandals That Brought Down the





65. Effron et al., supra note 61.
66. Id.
67. Kristin Jensen, Televangelist Bakker, Companies Warned by FDA, FTC on Fraudulent
Coronavirus Claims, BIOPHARMA DIVE (Mar. 11, 2020), https://www.biopharmadive.com/news/
fda-ftc-coronavirus-marketing-warning-fraudulent-claims/573948.
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like lodging at the resort and diverting that money to support his own ex-
travagant lifestyle.68
Although Bakker successfully played the part of a remorseful wrong-
doer who had learned the errors of his ways when his original forty-five-
year sentence was up for reconsideration following Bakker’s appeal in
1991, it appears the twenty-seven-year reduction69 he managed to finagle
was at least partly the result of Bakker’s skillful manipulation. Bakker man-
aged to shorten his sentence only to return unrehabilitated and to resume
scamming the American public. Following his release from prison, Bakker
started The Jim Bakker Show with his new wife, Lori Bakker, and he re-
sumed his televangelical scheme. This time, instead of over-selling shares
in a theme park, Bakker began preaching about the end of civilization and
selling “freeze-dried food by the five-gallon bucket load and survival gear”
to viewers.70 When the coronavirus outbreak hit, Bakker took advantage of
the panic and began marketing his colloidal silver product “Silver Solution”
as a treatment for COVID-19.71
Jim Bakker’s recent colloidal silver scheme has caught the eye of more
than the FDA and FTC; both the Missouri and New York Attorneys Gen-
eral are taking separate actions to stop his scams.72 The Missouri Attorney
General filed a lawsuit against Jim Bakker seeking a “permanent injunction
ordering Bakker to stop selling Silver Solution as a treatment for
coronavirus.”73 The Missouri Attorney General gave consumers the follow-
ing warning through a March 10, 2020, news release: “Anyone who has
bought ‘Silver Solution’ from the Jim Bakker Show should know that it
cannot cure or treat coronavirus.”74 The New York Attorney General’s of-
fice sent Bakker a cease and desist notice on March 3, 2020.75 The New
York Attorney General’s office warned its citizens through a March 10,
2020, press release that “scammers commonly exploit real public health
concerns and use heightened public fear to prey on consumers and profit
68. Jim Bakker Given Reduced Sentence, WASH. POST, https://www.washingtonpost.com/
archive/lifestyle/1991/08/24/jim-bakker-given-reduced-sentence/e99c6e27-0b7e-4c0f-848b-
5cf262cb67a0 (last visited Feb. 7, 2021).
69. Id.
70. Effron et al., supra note 61.
71. Warning Letter to Jim Bakker Show, supra note 60.
72. Ivan Pereira, NY, Missouri Attorneys General Order Companies to Stop Promoting Al-
leged Coronavirus Cures, ABC NEWS (Mar. 11, 2020), https://abcnews.go.com/US/ny-attorney-
general-orders-televangelist-jim-bakker-stop/story?id=69472032.
73. Erich Schmitt, AG Schmitt Files Suit Against Jim Bakker for Selling Fake “Coronavirus
Cure,” OFF. MO. ATT’Y GEN. (Mar. 10, 2020), https://ago.mo.gov/home/news/2020/03/10/ag-
schmitt-files-suit-against-jim-bakker-for-selling-fake-coronavirus-cure.
74. Id.
75. Cease and Desist Notification from State of New York Office of the Attorney General to
James Bakker (Mar. 3, 2020), https://www.ozarksfirst.com/wp-content/uploads/sites/65/2020/03/
bakker_cease_and_desist_letter_notification.pdf.
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from frauds related to those health fears” and reminded the public that there
was no FDA-approved vaccine or cure for COVID-19 at that time.76
Since the efforts of the FDA, FTC, and Missouri and New York Attor-
neys General to stop Jim Bakker’s colloidal silver hawking, it has been
reported that he has suffered from a stroke.77 The bright side for Bakker is
that, since being forced to stop selling colloidal silver, he should be fully
stocked with his magical potion to treat any ailments from home.
4. Gaia’s Whole Healing Essentials LLC
Another perpetrator in the colloidal silver scam called out by the FDA
and FTC was Gaia’s Whole Healing Essentials LLC (“Gaia”).78 The FDA
and FTC sent a joint warning letter to Gaia on April 1, 2020.79 As is typical
of the simple scammer, Gaia’s claims are outrageous and easily disproven,
such as its bold statement that colloidal silver is “the key to protecting your-
self” from the novel coronavirus and COVID-19.80 The company also al-
leged its colloidal silver is an effective treatment for “all types of infections
and diseases,” including lung disease.81
While the focus of the agencies’ warning letter was Gaia’s erroneous
claim that its colloidal silver products can prevent and fight COVID-19, the
company’s outlandish sales gimmicks do not stop there. After receipt of the
warning letter, Gaia continued to sell 16 ounces of colloidal silver for
$111.11 and claimed it was an effective treatment for, not only COVID-19,
but also the common cold, cancer, ulcers, yeast infections, tuberculosis,
Lyme’s disease, bubonic plague, pneumonia, leprosy, gonorrhea, syphilis,
scarlet fever, malaria, HIV/AIDS, shingles, diabetes, arthritis, lupus, leuke-
mia, gum disease, and many more diseases.82 It also claimed use during
pregnancy would “aid the baby’s growth and health as well as the mother’s
delivery and recovery.”83 Gaia has since replaced these specific health
claims related to colloidal silver with its bold general claim that its products
76. AG James: Price Gouging Will Not Be Tolerated, N.Y. ST. ATT’Y GEN. (Mar. 10, 2020),
https://ag.ny.gov/press-release/2020/ag-james-price-gouging-will-not-be-tolerated.
77. Joe Marusak, TV Pastor Jim Bakker Suffers Stroke, Wife and Son Confirm. ‘Jim will be
back!’, CHARLOTTE OBSERVER (May 8, 2020), https://www.charlotteobserver.com/news/local/
article242596441.html.
78. Warning Letter from U.S. Food & Drug Admin. and Fed. Trade Comm’n to Gaia’s






82. GAIA’S WHOLE HEALING ESSENTIALS, https://gaiaswholehealingessentials.org/Gaias-Col
loidal-Silver-16oz-p137163079 (last visited Apr. 27, 2020) (statements have been removed from
website).
83. Id.
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“heal any and all diseases, ailments, energetic imbalances and more.”84 It
continues to sell its colloidal silver as a “magical colloidal elixir” at the
increased price of $122.21.85
And although Gaia has since removed its explicit claims that its prod-
ucts can prevent and treat the coronavirus, its other erroneous claims re-
main. Apparently, for just over $100, Gaia’s magic solution will basically
cure anything. Of course, the problem with Gaia’s business model is that it
relies solely on the word of Gaia and its promoters. Gaia has failed to pro-
vide a shred of evidence to back up its claims. And while the company
admits to “the lack of research done” on the effects of its products, it alleges
this is due to some conspiracy.86 Specifically, Gaia alleges:
The lack of research comes from knowing how beneficial Colloi-
dal silver is for the human body and not wanting this medical
secret to be released as it will solve a vast majority of diseases
and issues humanity is experiencing, harming the profitability of
pharmaceuticals. . . . The truth about Colloidal silver is deeply
hidden from society as it is much cheaper than the medical reme-
dies recommended for the aforementioned diseases. This is an an-
cient treatment that has been used for many millennia. When used
properly with the correct dose and intentions, you will see that
Colloidal silver will heal your body in ways you could not even
fathom possible.87
These are odd allegations considering Gaia itself is the one responsible
for conducting the research and providing the scientific evidence to support
its claims. The FDA does not conduct independent testing, it evaluates the
totality of scientific evidence based on the procedures used and results ob-
tained from testing conducted by or on behalf of companies.88 And if a
company has satisfied the FDA’s requirements by supporting its claims that
a product can prevent or treat a disease with sound evidence, it will have no
issue with the FTC.89
Among Gaia’s bold but easily disproved claims is that “colloidal silver
is completely natural and therefore cannot harm you.”90 The logic of that
statement is plainly faulty. Many things found in nature are harmful and
even deadly. For example, aconite is a plant native to Europe that, if swal-
lowed, is known to cause death by asphyxiation.91 Mere skin contact with
84. Gaia’s Colloidal Silver, GAIA’S WHOLE HEALING ESSENTIALS, https://gaiaswholehealing




88. U.S. FOOD & DRUG ADMIN., FDA-2007-D-0371, GUIDANCE FOR INDUSTRY: EVIDENCE-
BASED REVIEW SYSTEM FOR THE SCIENTIFIC EVALUATION OF HEALTH CLAIMS (2009).
89. Fair, supra note 36.
90. GAIA’S WHOLE HEALING ESSENTIALS, supra note 82.
91. AMY STEWART, WICKED PLANTS 2 (2009).
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the plant can cause cardiac symptoms.92 “Aconite is so powerful that Nazi
scientists found it useful as an ingredient for poisoned bullets.”93 Consump-
tion of three or four castor bean seeds (a plant native to Eastern Africa and
Western Asia) is enough to kill a person.94 Asbestos (a naturally occurring
fibrous mineral once used for making fireproof materials) was banned by
the EPA in 1989 because it caused lung disease from contact or inhala-
tion.95 Other examples of natural poisons include arsenic, mercury, formal-
dehyde, and anthrax, to name a few.96 Clearly, natural is not synonymous
with being safe.
5. JRB Enterprise Group d/b/a Anti Aging Bed
Yet another bad actor anxious to get in on profiting off the pandemic is
JRB Enterprise Group d/b/a Anti Aging Bed (“Anti Aging Bed”). As its
name suggests, the company sells mattresses and accessories, but appar-
ently could not resist the urge to get in on the COVID-19 panic and began
selling colloidal silver products as alleged protection against the
coronavirus. Anti Aging Bed claimed inhaling colloidal silver through a
nebulizer “provides a real prevention regiment for a number of maladies –
including the Corona Virus [sic] known as COVID19.”97 As is common
with the simple scammer, a consumer should quickly become suspicious by
looking at the scam on its face. A company that sells mattresses and then
randomly throws in a magic “treatment” for a novel virus should immedi-
ately raise a red flag. Most consumers do not expect to receive medical
treatments from a specialty mattress business.
Anti Aging Bed was selling its “Colloidal Silver CoronaVirus Conve-
nience Package” for $150 (on sale from $300).98 The company asserted,
without support, that “numerous tests at major universities and commercial
labs . . . have proven the effectiveness of silver.”99
Perhaps in response to the warning letter sent to Anti Aging Bed on
March 20, 2020,100 by the FDA and FTC, the company’s website tempora-
rily included the following disclaimer: “These statements have not been
92. Id.
93. Id.
94. Id. at 15–16.
95. Sarah Zielinski, Ten Natural Products That Kill, SMITHSONIAN MAG. (Nov. 9, 2010),
https://www.smithsonianmag.com/science-nature/ten-natural-products-that-kill-38268113.
96. Id.
97. Warning Letter from U.S. Food & Drug Admin. and Fed. Trade Comm’n to JRB Enter-
prise Group Inc. DBA Anti Aging Bed (Mar. 30, 2020), https://www.fda.gov/inspections-compli
ance-enforcement-and-criminal-investigations/warning-letters/jrb-enterprise-group-inc-dba-anti-
aging-bed-605892-03302020.
98. ANTI AGING BED, https://antiagingbed.com/products/colloidal-silver-coronavirus-conveni
ence-package?_pos=1&_sid=58ad3396c&_ss=r# (last visited Feb. 7, 2021) (statements and prod-
uct have been removed from website).
99. Id.
100. Warning Letter to JRB Enterprise Group, supra note 97.
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evaluated by the Food and Drug Administration. This product is not in-
tended to diagnose, treat, cure or prevent any disease.”101 Anti Aging Bed
stated the disclaimer was “posted under protest” and that the FDA’s re-
quirement to include the disclaimer is a violation of the company’s First
Amendment rights.102 And while corporations do have legal rights in the
United States, in order for commercial speech to receive protection it “must
concern lawful activity and not be misleading.”103 It is well-established that
inaccurate commercial speech is not protected and may be banned where it
is “more likely to deceive the public than to inform it.”104
In approximately mid-April, Anti Aging Bed removed its colloidal sil-
ver products and the above-mentioned disclaimer and accompanying protest
from its website. Apparently, for the time being, the company decided to
stick to mattress sales.
B. Essential Oils
Colloidal silver scammers are not the only ones quick to get in the
game of turning fake cures for a profit. Many businesses are pushing essen-
tial oils as an effective way to prevent, mitigate, and treat COVID-19. Like
colloidal silver, essential oils have been sold as a cure-all, without any sup-
port for such claims, for quite some time.
The deceptive practice of companies advertising their essential oil
products as anti-viral is not a special gimmick thought up for the
coronavirus. These companies have routinely popped up to claim, without
supporting evidence, that their essential oil products cure virtually every
illness under the sun, including whatever the ailment of the hour might be.
For example, Young Living was sent a warning letter from the FDA on
September 22, 2014, requiring it to correct its inaccurate claims that its
products could cure Ebola.105 Young Living made claims such as: “Viruses
(including Ebola) are no match for Young Living Essential Oils” and
“Ebola Virus can not [sic] live in the presence of cinnamon bark (this is in
Thieves) nor Oregano.”106 Additionally, Young Living’s consultants were
advertising its oils as treatments for “Parkinson’s disease, autism, diabetes,
hypertension, cancer, insomnia, heart disease, post-traumatic stress disorder
(PTSD), dementia, and multiple sclerosis,” among other conditions “that
101. ANTI AGING BED, supra note 98 (internal quotations omitted) (statements and product
have been removed from website).
102. Id.
103. Thompson v. W. States Med. Ctr., 535 U.S. 357, 357 (2002).
104. Cent. Hudson Gas & Elec. Corp. v. Pub. Serv. Comm’n of New York, 447 U.S. 557, 563
(1980).
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are not amenable to self-diagnosis and treatment by individuals who are not
medical practitioners.”107
With the recent coronavirus outbreak, peddlers of essential oils have
another ailment to add to their list of what their products allegedly cure.
1. Quinessence Aromatherapy
The FDA and FTC sent a joint warning letter to Quinessence
Aromatherapy Ltd. (“Quinessence”) on March 6, 2020, requiring it to cor-
rect fraudulent claims made in its advertisements.108 Quinessence was ad-
vertising “Essential Oils to Protect Against Coronavirus” and made
unsupported claims such as “there are a wide range of essential oils that
have been clinically proven to possess antiviral properties.”109 Quinessence
went on to promote twenty of its essential oil products as “the most power-
ful” protection against the coronavirus.110
Sometime following receipt of that warning letter, Quinessence re-
moved its direct claims that its essential oils could protect consumers
against the coronavirus, but indirect claims remain. A few examples of Qui-
nessence’s many current claims include, but are not limited to, that its Star
Anise Essential Oil “has powerful antimicrobial properties, and when
vaporised, it has a clearing action on the respiratory system,” that its Bay
Leaf Essential Oil is “antiseptic and antibacterial” and vaporizing it “is
helpful with a wide range of respiratory conditions,” and that its Bergamot
Essential Oil “is an effective antiseptic that helps guard against infec-
tion.”111 Only time will tell if the FDA and FTC will let Quinessence get
away with these thinly veiled coronavirus cure claims. As of the date of this
writing, public records do not indicate that any further action has been taken
against Quinessence.
2. Guru Nanda LLC
Guru Nanda LLC was also sent a warning letter by the FDA and FTC
on March 6, 2020, requesting the company to correct its fraudulent state-
ments that its essential oils would prevent and treat COVID-19.112 Guru
Nanda claimed “municipalities of Wuhan have declared that people should
use Pure essential oils as a preventative therapy” for the coronavirus and
107. Id.
108. Warning Letter from U.S. Food & Drug Admin. and Fed. Trade Comm’n to Quinessence




111. Essential Oils A - B, QUINESSENCE, https://www.quinessence.com/essential-oils/oils/a-b
(last visited Jan. 30, 2021).
112. Warning Letter from U.S. Food & Drug Admin. and Fed. Trade Comm’n to GuruNanda
LLC (Mar. 6, 2020), https://www.fda.gov/inspections-compliance-enforcement-and-criminal-in
vestigations/warning-letters/gurunanda-llc-604930-03062020.
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that “essential oils are effective against a diverse range of pathogens.”113
Additionally, according to the Orange County Register, Guru Nanda adver-
tised a 50 percent discount to consumers who entered the code “CORONA”
at checkout.114
Sometime after receipt of the warning letter, Guru Nanda removed the
direct claims that its essential oils could prevent COVID-19. However, like
Quinessence, Guru Nanda continued to make deceptive claims to consum-
ers about its products’ ability to treat ailments. For example, while Guru
Nanda removed its explicit COVID-19 claims from its webpage for its
“Whole Body Essential Oils Set,” it continued to display a picture of the
box which stated the following:
Guru Nanda’s natural Whole Body Benefit Pack, is a complete at
home FARM-ACY that will help maintain optimal well-being
from head to feet. Our in-house certified aromatherapist worked
hundreds of hours to bring the most effective synergy blends to
support your daily health needs all year long.115
The Whole Body Essential Oils Set included a product Guru Nanda
labeled “Immunity.”116 Viewed as a whole, clearly this advertisement was
intended to mislead consumers into believing its products aid your body’s
ability to ward off various health ailments without specifically naming the
coronavirus. Guru Nanda has since removed its advertisements for its
“Whole Body Essential Oils Set,” and has largely cleaned up its deceptive
claims, although it continues to sell “Immunity” and has added a product
labeled “Breathe Easy.”117 Public records do not currently indicate that the
FDA or FTC have taken further action against Guru Nanda, and the com-
pany appears to have largely cleaned up its act in recent months.
3. Health Mastery Systems d/b/a Pure Plant Essentials
On April 1, 2020, the FDA and FTC sent a joint letter to Health Mas-
tery Systems d/b/a Pure Plant Essentials (“Pure Plant”) warning it to correct
its fraudulent advertisements claiming its essential oils could prevent and
mitigate the symptoms of COVID-19.118
113. Id.
114. Jonathan Lansner, Coronavirus Warning: Buena Park Firm Told to Stop Pitching Oils as
Cures, ORANGE CNTY. REG. (Mar. 10, 2020), https://www.ocregister.com/2020/03/10/feds-warn-
buena-park-firm-warn-about-pitching-coronavirus-cures.
115. GURU NANDA, https://www.gurunanda.com/products/whole-body-essential-oils-set (last
visited Feb. 7, 2021) (statements and product have been removed from website).
116. Id.
117. Guru Nanda 100% Pure Essential Oil Blends - Set of 6, 10 ml Each, GURU NANDA,
https://gurunanda.com/top-6-blends-set-of-6-essential-oil-blends (last visited Dec. 23, 2020).
118. Warning Letter from U.S. Food & Drug Admin. and Fed. Trade Comm’n to Health Mas-
tery Systems DBA Pure Plant Essentials (Apr. 1, 2020), https://www.ftc.gov/system/files/warn
ing-letters/fda-covid-19-letter-health_mastery_systems_dba_pure_plant.pdf.
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Like the earlier-described essential oil companies, Pure Plant appears
to have removed its direct claims about being able to fight COVID-19, but
it continues to boast its products as a cure-all without specifically mention-
ing the coronavirus. For example, Pure Plant is selling a book called “Es-
sential Oils for Immunity” that purportedly describes the eighteen “best
pure essential oils to use for antimicrobial properties” and includes “re-
search studies proving effectiveness.”119 Pure Plant claims essential oils are
“potent antimicrobial agents” that “have a regulating effect on the body’s
[immune] responses to keep them in balance, [and help] when they’ve got-
ten out of balance as in the case of illness.”120 Public records do not indi-
cate any further action has been taken by the FDA or FTC against Pure
Plant at this time.
VI. THE CREATIVE CHARLATAN—WHERE WE ARE HEADED
Next, I am going to discuss the second category of fraudsters that I
have named the creative charlatans. Creative charlatans run much more
complex scams than those of the simple scammer. These schemes are much
harder to detect because their creators appropriate and misapply legitimate
science. Use of valid medical and scientific terms gives the scams an air of
validity and confuses consumers who do not have the in-depth knowledge
required to evaluate the claims.
It is virtually inevitable that as vaccines and treatments for the
coronavirus begin to be developed and valid clinical studies are underway,
creative charlatans will jump in to profit by appropriating some of the valid
research being conducted and claiming the government is interfering with
allowing providers to perform effective treatments. If it sounds compli-
cated, it is because it is supposed to be. The creative charlatan’s recipe is a
dash of science and a cup of confusion.
A. Exaggeration of Scientific Advancements—Stem Cell Therapies
To understand where we are heading with coronavirus scams, it is im-
portant to evaluate where we have been. The trending complex scheme
prior to the pandemic was fraudulent stem cell treatments. These faux treat-
ments are an example of what we can anticipate creative charlatans will
flood the market with, in response to the current pandemic, if the opportu-
nity remains for them to reap any financial gain from doing so.
Legitimate stem cell treatments consist of an extraction of tissue from
a specimen, either the patient or a donor, and then intravenous administra-
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tion into the patient.121 All stem cell treatments on humans are required to
take certain registration, manufacturing, and reporting steps to prevent the
introduction, transmission, and spread of communicable disease.122 Many
such treatments are considered biological products by the FDA and thus
also require pre-market approval prior to being administered on a human.123
Because of the invasive nature of the treatments, manufacturers are required
to first demonstrate through animal studies that proposed treatments are
safe and effective.124 Next, manufacturers are required to conduct FDA-
approved clinical studies.125 The clinical studies must be designed to ensure
the safety of participants.126 Once the manufacturer has satisfied the re-
quirements of this stage, it can request pre-market approval from the FDA,
which will be granted so long as the prior studies have shown the treatments
are both safe and effective.127
The rationale for these FDA regulations is to prevent providers from
making unfounded promises to vulnerable patients “while continuing to en-
courage innovation so that the medical industry can properly harness the
potential of stem cell products.”128 The FDA warns consumers about unap-
proved stem cell therapies. “Researchers hope stem cells will one day be
effective in the treatment of many medical conditions and diseases. But
unproven stem cell treatments can be unsafe.”129 Some risks include blind-
ness (when stem cells are injected into the eye), growth of tumors, adminis-
tration site reactions, the ability of cells to move from placement sites and
change into inappropriate cell types or multiply, failure of cells to work as
expected, and contamination of cells prior to injection (in cases where cells
are manipulated after extraction).130 These risks are present even if the stem
cells used are taken from and injected back into the same patient.131
Currently, the only FDA-approved stem cell treatment is the use of
blood-forming stem cells derived from umbilical cord blood to treat patients
with certain blood disorders.132 However, there are many experimental stem
cell treatments that are currently undergoing FDA-approved clinical stud-
121. Arezu Sarvestani, Stem Cell Therapy: What’s Real and What’s Not at California’s For-
Profit Clinics, U.C.S.F. (Nov. 1, 2019), https://www.ucsf.edu/news/2019/11/415811/stem-cell-
therapy-whats-real-and-whats-not-californias-profit-clinics.
122. FDA Human Cells, Tissues, and Cellular and Tissue-Based Products, 21 C.F.R.
§ 1271.10.
123. Id.







130. FDA Warns About Stem Cell Therapies, U.S. FOOD & DRUG ADMIN., https://www.
fda.gov/consumers/consumer-updates/fda-warns-about-stem-cell-therapies (Sep. 3, 2019).
131. Id.
132. Id.
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ies.133 For example, the Mayo Clinic in Rochester, Minnesota, is con-
ducting a study related to treating multiple system atrophy.134 The
University of Texas Health Science Center in Houston, Texas, is con-
ducting a study related to Parkinson’s disease.135 TCA Cellular Therapy
LLC in Covington, Louisiana,136 and Jewish Hospital in Louisville, Ken-
tucky,137 are conducting separate studies related to the treatment of coro-
nary disease. The University of Minnesota in Minneapolis, Minnesota, is
conducting a study related to patients experiencing heart failure who are
undergoing a ventricular assist device placement.138 The University Hospi-
tal Cleveland Medical Center in Cleveland, Ohio,139 and McConnell Spine,
Sport, and Joint Physicians in Columbus, Ohio,140 are conducting separate
studies related to treatments of knee osteoarthritis. The Medical University
of South Carolina is conducting a study related to the treatment of Type 1
diabetes.141 This is only a small selection of the FDA-approved clinical
stem cell studies currently being conducted in the United States. These le-
gitimate studies are narrowly tailored and subject to scientific rigor.142
Clearly, promising research is underway which explores the potential
applications for stem cells in treating a wide array of ailments. However,
research takes time and resources, and some “unscrupulous actors . . . have
seized on the clinical promise of regenerative medicine, while exploiting
the uncertainty, in order to make deceptive, and sometimes corrupt, assur-
ances to patients based on unproven, and in some cases, dangerously dubi-
ous products.”143 These bad actors promote “unproven, clearly illegal, and
133. Id.
134. Mesenchymal Stem Cell Therapy in Multiple System Atrophy, U.S. NAT’L LIBR. MED.,
ClinicalTrials.gov (search condition or disease field for “NCT02315027”).
135. Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Par-
kinson’s Disease, U.S. NAT’L LIBR. MED., ClinicalTrials.gov (search condition or disease field for
“NCT02611167”).
136. Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia, U.S.
NAT’L LIBR. MED., ClinicalTrials.gov (search condition or disease field for “NCT00643981”).
137. Cardiac Stem Cell Infusion in Patients with Ischemic CardiOmyopathy, U.S. NAT’L LIBR.
MED., ClinicalTrials.gov (search condition or disease field for “NCT00474461”).
138. Stem Cell Therapy in Patients with Severe Heart Failure & Undergoing Left Ventricular
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icalTrials.gov (search condition or disease field for “NCT03477942”).
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often expensive treatments that offer little hope, and, even worse, may pose
significant risks to the health and safety of vulnerable patients.”144
One complexity of the creative charlatan that makes his scam difficult
for consumers to detect is that he claims to treat conditions that “normally
improve or fluctuate over time, such as joint pain, low back pain, arthritis,
or multiple sclerosis.”145 In the case of fraudulent stem cell treatments, the
creative charlatan boasts they will regrow lost tissue, despite there being
“no solid evidence” to back up such claims.146 Patients who feel better after
the treatments may believe it is because of these fraudulent treatments, but
the truth is that they would likely have felt better anyway due to the natural
fluctuation of the ailment suffered. Then when the symptoms flair up again,
these fraudsters can lure the consumer back in for another treatment.
The FDA stated in a 2017 news release: “We will take a firm stance
against those that prey on the medical promise of regenerative cell therapies
to market treatments potentially unsafe or unproven so-called cures.”147 As
promised, the FDA has been calling out bad actors selling unproven stem
cell treatments to consumers across the country.
1. Liveyon Labs Inc. and Liveyon LLC
The FDA issued a warning letter on December 5, 2019, to Liveyon
Labs Inc. and Liveyon LLC (“Liveyon”) following the agency’s inspection
of the labs.148 Therein, the FDA noted Liveyon was in violation of FDA
regulations requiring the business to have either pre-market approval or be
operating an FDA-approved clinical study to legally manufacture umbilical
cord blood for distribution to stem cell therapy centers for eventual injec-
tion into humans.149 Additionally, the FDA alerted Liveyon of many “sig-
nificant deviations from current good manufacturing practice . . . and
current good tissue practice.”150 The FDA informed Liveyon that its “defi-
cient donor eligibility practices, inadequate aseptic practices, and deficient
environmental monitoring . . . pose a significant risk that [its] products may




145. Sarvestani, supra note 121.
146. Liz Szabo, Why Expensive, Unproven Stem Cell Treatments Are a New Health Care
Trend, KAISER HEALTH NEWS (Apr. 4, 2019, 8:00 AM), https://www.pbs.org/newshour/tag/stem-
cells.
147. FDA Warns US Stem Cell Clinic of Significant Deviations, U.S. Food & Drug Admin.,
(Mar. 27, 2018), https://www.fda.gov/news-events/press-announcements/fda-warns-us-stem-cell-
clinic-significant-deviations.
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defects.”151 More specifically, during its inspection, the FDA observed a
failure of Liveyon to review donor medical records or to use FDA-approved
donor screening tests to detect risk factors, such as the presence of a com-
municable disease.152 Liveyon also failed to establish and follow steriliza-
tion procedures to prevent contamination of its product.153 Further, Liveyon
was found to have failed to investigate issues or implement corrective or
preventative actions, including instances where umbilical cord blood ar-
rived from donors who tested positive for Zika virus, Hepatitis B, syphilis,
and instances where batches of the product were contaminated and then
distributed to providers.154
2. Regenerative Medical Group and Telehealth Medical Group
In addition to the actions taken by the FDA, the FTC is also on the
watch for creative charlatans making claims that are not supported by scien-
tific evidence. Fairly recently, the FTC succeeded in a suit for deceptive
advertisement against Dr. Bryan Henderson and the two companies he
owned and operated: Regenerative Medical Group and Telehealth Medical
Group.155 Henderson claimed that the stem cell therapies offered through
his companies could treat and cure a variety of serious illnesses, including
Parkinson’s disease, autism, dementia, depression, multiple sclerosis, cere-
bral palsy, traumatic brain injury, heart disease, macular degeneration,
chronic kidney disease, osteoarthritis, and stroke.156 Henderson charged
consumers between $9,500 and $15,000 for initial stem cell injections and
then an additional $5,000 to $8,000 for each follow up “booster”
treatment.157
The FTC succeeded in its suit against Henderson and was granted per-
manent injunctive relief requiring Henderson and both of his companies to
“stop claiming its stem cell therapy treats or cures any disease or health
condition and to stop claiming that its stem cell therapy is comparable or




154. Warning Letter from U.S. Food & Drug Admin. to Liveyon Labs Inc., supra note 148.
155. FTC Returns Almost $515,000 to Consumers Who Bought Deceptively Marketed “Amni-
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bought-deceptively.
156. Colleen Tressler, FTC Takes Aim at Deceptive Stem Cell Therapy Claims, FED. TRADE
COMM’N (Oct. 18, 2018), https://www.consumer.ftc.gov/blog/2018/10/ftc-takes-aim-deceptive-
stem-cell-therapy-claims.
157. FTC Stops Deceptive Health Claims by a Stem Cell Therapy Clinic, FED. TRADE COMM’N
(Oct. 18, 2018), https://www.ftc.gov/news-events/press-releases/2018/10/ftc-stops-deceptive-
health-claims-stem-cell-therapy-clinic.
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ing any disease or health condition.” The court also awarded $3.31 million
to the FTC to provide refunds to affected customers.158
Combatting creative charlatans has proved a difficult task in an age of
seamless mobility and online platforms. Prior to the coronavirus outbreak,
these scammers were already widespread and hard to nail down. Where we
sit today, in the heart of a global pandemic, it is necessary to take a proac-
tive, rather than a reactive, approach to consumer protection.
VII. CONCLUSION
The World Health Organization (WHO) has brought experts together
from around the world in an attempt to discover an effective treatment for
the novel coronavirus.159 These researchers have collaborated to identify
animal models that mirror human reactions to the virus, which has allowed
them to complete animal studies applicable to controlled clinical trials on
humans.160 But real science takes time. Currently, no COVID-19 vaccine
has received WHO approval, although three have been authorized for use
by certain national authorities.161 Since the original coronavirus outbreak,
two variants have been detected, one in the UK and one in South Africa.162
A lot of uncertainty remains with respect to this virus, and that is unlikely to
change for some time. Unfortunately, all of the unknowns create the perfect
breeding ground for the ploys of the creative charlatan.
Creative charlatans will undoubtedly exploit budding research now
that valid clinical studies are underway and vaccines are beginning to roll
out. As of this writing, the demand for vaccination far exceeds the supply
available.163 Creative charlatans will surely be quick to meet that demand
with pseudo-treatments. And because many people who contract the
coronavirus are asymptomatic and many will recover naturally, it is all too
easy for bad actors to sell nonsense products and to attribute any natural
recovery or lack of symptoms to their effects. With no comprehensive con-
tact tracing in effect, in the context of the coronavirus, the lives that will be
lost if such scams are not prevented will be incalculable. Individuals operat-
ing under the false belief that they have some sort of immunity toward the
158. FTC Returns Almost $515,000, supra note 155.
159. R&D Blueprint and COVID-19, WORLD HEALTH ORG., https://www.who.int/teams/
blueprint/covid-19 (last visited Jan. 30, 2021).
160. Id.
161. Coronavirus Disease (COVID-19): Vaccines, WORLD HEALTH ORG., https://
www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/
coronavirus-disease-(covid-19)-vaccines (last visited Jan. 30, 2021).
162. WHO’s Science in 5 on COVID-19: Variants and Vaccines, WORLD HEALTH ORG. (Jan.
8, 2021), https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/sci
ence-in-5/episode-20---covid-19---variants-vaccines.
163. Caitlin Owens, Demand for Coronavirus Vaccines Is Outstripping Supply, AXIOS (Jan.
19, 2021), https://www.axios.com/demand-coronavirus-vaccines-outstripping-supply-7314861f-
d8f0-4ee8-8480-85fea99846f8.html.
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virus put everyone they come in contact with, and the subsequent contact
chain of those thereafter, at substantial risk of contracting a deadly virus
with no known cure.
The current climate puts consumers at great risk for falling for the
gimmicks of the creative charlatan. Consumers do not want to be afraid.
They do not want to accept that there are no good answers, that they have to
be patient while scientists and medical professionals around the world
scramble to come up with a safe and effective means of combatting the
virus, and that in the interim, everyone’s health is in danger. It is much
more comforting to believe those crying conspiracy or to accept the gim-
micks of a creative charlatan who claims to have it all figured out than it is
to sit with the reality of the situation.
Protecting consumers from the preying hands of the creative charlatan
is more crucial now than ever. And while I have no doubt that minds much
greater than mine are thinking up ways to combat this inevitable problem, I
am going to share my proposed solution: strict liability for any individual or
business that makes a coronavirus treatment, prevention, or cure claim
without preapproval from the FDA, with an automatic $500,000 fine for
each such claim. No warning letters. No slap on the wrist. No opportunity
to defend dangerous claims. I would propose these claims be addressed by a
joint task force between the FTC and FDA, that new regulations be enacted
as necessary, and that these new regulations be enforced by the US Attor-
ney General.
Because these scammers are profit motivated, such schemes need to be
chopped off at the knees before any profit can be realized. Creative charla-
tans are not stupid, and if there is proper deterrence in place which shows
them that rolling out fake coronavirus products is going to lose them
money, most will be deterred from doing so, and those who are not will
promptly find themselves in an inoperable business model.
While my proposal is intentionally harsher than the current FDA-FTC
enforcement models, it is not an entirely radical idea. The FTC is already
authorized to issue cease and desist orders against individual offenders en-
gaging in unfair or deceptive advertising.164 Once such an order is issued,
the US Attorney General may bring a suit against the named offender for a
civil penalty of up to $10,000 for each violation of the Commission’s or-
der.165 What I am proposing is that the FTC issue a blanket order, rather
than chasing down individual actors after the fact, that no individual or
company shall make any claim that its product can treat or prevent COVID-
19 without prior FDA approval. An FDA-FTC pandemic task force would
be created to detect violators, who would face a $500,000 penalty for each
violation of the FTC’s general order.
164. 15 U.S.C. § 45(b).
165. 15 U.S.C. § 45(l).
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The cost of human lives paid for the coronavirus is already much too
high. We must be proactive in preventing creative charlatans from profiting
off society’s fear and making an already bad problem much worse.
